Skip to main content
. 2014 Jun 27;17(2):129–135. doi: 10.4048/jbc.2014.17.2.129

Table 3.

Tumor size and axillary lymph node involvement in the BRCA1 and BRCA2 groups compared to triple-negative and non-triple-negative breast cancer in the registry group

graphic file with name jbc-17-129-i003.jpg

OR=odds ratio of positivity of axillary lymph node involvement; Registry=patients of registry data; Non-TNT=non-triple-negative tumor; TNT=triple-negative tumor.